Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.
Maheu E, Zaim M, Appelboom T, Jeka S, Trc T, Berenbaum F, Maasalu K, Berenbaum F. Maheu E, et al. Among authors: berenbaum f. Clin Exp Rheumatol. 2011 May-Jun;29(3):527-35. Epub 2011 Jun 29. Clin Exp Rheumatol. 2011. PMID: 21722501 Clinical Trial.
A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis.
Berenbaum F, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G, Chevalier X, Rannou F, Rovati LC, Maheu E. Berenbaum F, et al. Ann Rheum Dis. 2012 Sep;71(9):1454-60. doi: 10.1136/annrheumdis-2011-200972. Epub 2012 Jan 31. Ann Rheum Dis. 2012. PMID: 22294639 Free PMC article. Clinical Trial.
"Let's talk about OA pain": a qualitative analysis of the perceptions of people suffering from OA. Towards the development of a specific pain OA-Related questionnaire, the Osteoarthritis Symptom Inventory Scale (OASIS).
Cedraschi C, Delézay S, Marty M, Berenbaum F, Bouhassira D, Henrotin Y, Laroche F, Perrot S. Cedraschi C, et al. Among authors: berenbaum f. PLoS One. 2013 Nov 11;8(11):e79988. doi: 10.1371/journal.pone.0079988. eCollection 2013. PLoS One. 2013. PMID: 24244589 Free PMC article.
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.
Hochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Doménech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP; MOVES Investigation Group. Hochberg MC, et al. Among authors: berenbaum f. Ann Rheum Dis. 2016 Jan;75(1):37-44. doi: 10.1136/annrheumdis-2014-206792. Epub 2015 Jan 14. Ann Rheum Dis. 2016. PMID: 25589511 Free PMC article. Clinical Trial.
Translation of clinical problems in osteoarthritis into pathophysiological research goals.
van der Kraan PM, Berenbaum F, Blanco FJ, Cosimo de B, Lafeber F, Hauge E, Higginbottom A, Ioan-Facsinay A, Loughlin J, Meulenbelt I, Moilanen E, Pitsillidou I, Tsezou A, van Meurs J, Vincent T, Wittoek R, Lories R; EULAR Study group in OA (http://www.eular.org/investigative_rheumatology_study_groups.cfm). van der Kraan PM, et al. Among authors: berenbaum f. RMD Open. 2016 May 26;2(1):e000224. doi: 10.1136/rmdopen-2015-000224. eCollection 2016. RMD Open. 2016. PMID: 27252894 Free PMC article.
A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC. Fleischmann RM, et al. Among authors: berenbaum f. Arthritis Rheumatol. 2019 Jul;71(7):1056-1069. doi: 10.1002/art.40840. Epub 2019 Jun 7. Arthritis Rheumatol. 2019. PMID: 30653843 Free article. Clinical Trial.
The opioid epidemic: helping rheumatologists prevent a crisis.
Trouvin AP, Berenbaum F, Perrot S. Trouvin AP, et al. Among authors: berenbaum f. RMD Open. 2019 Aug 6;5(2):e001029. doi: 10.1136/rmdopen-2019-001029. eCollection 2019. RMD Open. 2019. PMID: 31452932 Free PMC article. Review.
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Berenbaum F, Blanco FJ, Guermazi A, Miki K, Yamabe T, Viktrup L, Junor R, Carey W, Brown MT, West CR, Verburg KM. Berenbaum F, et al. Ann Rheum Dis. 2020 Jun;79(6):800-810. doi: 10.1136/annrheumdis-2019-216296. Epub 2020 Mar 31. Ann Rheum Dis. 2020. PMID: 32234715 Free PMC article. Clinical Trial.
411 results